Evidence map›Paper›PMID 25779657›Full record

ArticleOncotarget2015

Elevated Src family kinase activity stabilizes E-cadherin-based junctions and collective movement of head and neck squamous cell carcinomas.

Laurence Veracini, Dominique Grall, Sébastien Schaub, Stéphanie Beghelli-de la Forest Divonne, Marie-Christine Etienne-Grimaldi, Gérard Milano, Alexandre Bozec, Emmanuel Babin, Anne Sudaka, Juliette Thariat and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Review
  3. Partial EMT in Squamous Cell Carcinoma: A Snapshot.International journal of biological sciences · 2021
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Metastasis as a systemic disease: molecular insights and clinical implications.Biochimica et biophysica acta. Reviews on cancer · 2019
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Adherens Junction and E-Cadherin complex regulation by epithelial polarity.Cellular and molecular life sciences : CMLS · 2016
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Laurence VeraciniUniversity of Nice Sophia Antipolis, UFR Sciences, Nice, France.
Dominique GrallUniversity of Nice Sophia Antipolis, UFR Sciences, Nice, France.
Sébastien SchaubUniversity of Nice Sophia Antipolis, UFR Sciences, Nice, France.
Stéphanie Beghelli-de la Forest DivonneUniversity of Nice Sophia Antipolis, UFR Sciences, Nice, France.
Marie-Christine Etienne-GrimaldiLaboratory of Oncopharmacology, Centre Antoine Lacassagne, Nice, France.
Gérard MilanoLaboratory of Oncopharmacology, Centre Antoine Lacassagne, Nice, France.
Alexandre BozecDepartment of Otorhinolaryngology, Centre Antoine Lacassagne, Nice, France.
Emmanuel BabinDepartment of Otorhinolaryngology and Cervicofacial Surgery, CHU, Caen, France.
Anne SudakaDepartment of Pathology, Centre Antoine Lacassagne, Nice, France.
Juliette ThariatUniversity of Nice Sophia Antipolis, UFR Sciences, Nice, France.
Ellen Van Obberghen-SchillingUniversity of Nice Sophia Antipolis, UFR Sciences, Nice, France.
Centre Antoine Lacassagne · FRInserm · FRCentre Hospitalier Universitaire de Caen · FRCentre National de la Recherche Scientifique · FRUniversité Côte d'Azur · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

EGF receptor (EGFR) overexpression is thought to drive head and neck carcinogenesis however clinical responses to EGFR-targeting agents have been modest and alternate targets are actively sought to improve results. Src family kinases (SFKs), reported to act downstream of EGFR are among the alternative targets for which increased expression or activity in epithelial tumors is commonly associated to the dissolution of E-cadherin-based junctions and acquisition of a mesenchymal-like phenotype. Robust expression of total and activated Src was observed in advanced stage head and neck tumors (N=60) and in head and neck squamous cell carcinoma lines. In cultured cancer cells Src co-localized with E-cadherin in cell-cell junctions and its phosphorylation on Y419 was both constitutive and independent of EGFR activation. Selective inhibition of SFKs with SU6656 delocalized E-cadherin and disrupted cellular junctions without affecting E-cadherin expression and this effect was phenocopied by knockdown of Src or Yes. These findings reveal an EGFR-independent role for SFKs in the maintenance of intercellular junctions, which likely contributes to the cohesive invasion E-cadherin-positive cells in advanced tumors. Further, they highlight the need for a deeper comprehension of molecular pathways that drive collective cell invasion, in absence of mesenchymal transition, in order to combat tumor spread.

Indexed as

CadherinsCarcinoma, Squamous CellCell Line, TumorHead and Neck NeoplasmsHumansSignal Transductionsrc-Family KinasesCadherinssrc-Family Kinasescollective migrationE-cadherinhead and neck cancerSrc kinases

Identifiers

PMID25779657
PMCPMC4480700
OpenAlexW2158561889

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.